Over 55 novel ophthalmic products are currently available / being developed for various therapeutic Knowpia

Advancements in the domain of ophthalmology continue to expand the range of potential application areas for contact lenses. Presently, over 55 novel ophthalmic products have been developed or are being developed for the treatment of various ophthalmological disorders, diagnosis / monitoring of diseases and for restoring vision in the blind. The ongoing efforts to innovate in this domain are evident from the fact that more than 7,500 patents have been granted / filed since 2013.

To order this 230+ page report, which features 115+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/next-generation-contact-lenses-and-visual-prostheses-market-2019-2030/244.html

The USD 3.7 billion (by 2030) financial opportunity within the next generation immune checkpoint modulators market has been analyzed across the following segments:

§ Type of Product

§ Contact Lenses

§ Visual Prostheses

§ Type of Lenses

§ Therapeutic Contact Lenses

§ Drug-eluting Contact Lenses

§ Diagnostics and Monitoring Contact Lenses

§ Target Indication

§ Age-related Macular Degeneration

§ Aniridia

§ Diabetes

§ Glaucoma

§ Retinitis Pigmentosa

§ Key Geographical Region

§ North America

§ EU5

§ Asia-Pacific

The “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030.” report features the following technologies, which we identified to be key players in this domain:

§ EyePrint Prosthetics

§ University of Washington

§ Leo Lens Technology

§ Baylor College of Medicine

§ iBIONICS

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Promotional Analysis

6. Technology Profiles

7. Patent Analysis